http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112569252-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1273 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 |
| filingDate | 2020-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112569252-B |
| titleOfInvention | Application of pyracantha fortuneana polysaccharide, pharmaceutical composition containing pyracantha fortuneana polysaccharide and drug-loaded vesicle containing pharmaceutical composition |
| abstract | The invention provides application of pyracantha fortuneana polysaccharide, a pharmaceutical composition containing pyracantha fortuneana polysaccharide and a drug-loaded vesicle containing the pharmaceutical composition, and belongs to the technical field of biological medicine. Meanwhile, the pyracantha fortuneana polysaccharide and the chemotherapeutic drug are wrapped in the drug-carrying vesicle, and in-vitro killing and apoptosis experiments prove that the drug-carrying vesicle formed by combining the pyracantha fortuneana polysaccharide and the chemotherapeutic drug can play a targeting role, so that the sensitivity of the chemotherapeutic drug to tumor cells is further improved, the drug effect of the chemotherapeutic drug is more favorably played, the antioxidant stress effect of the chemotherapeutic drug can be enhanced, and the effects of synergism and attenuation are achieved. |
| priorityDate | 2020-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.